Dr. Eric Marsh, MD, PhD
Claim this profileChildren's Hospital of Philadelphia
Studies Rett Syndrome
Studies Myoclonic Astatic Epilepsy
6 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Eric Marsh, MD, PhD is currently running
EPX-100
for Dravet Syndrome
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children and adult participants with Dravet syndrome (DS).
Recruiting1 award Phase 39 criteria
EEG and Evoked Potentials
for Rett Syndrome
The goal of this observational study is to identify candidate biomarkers in individuals with Rett Syndrome (RTT). The main questions it aims to answer are: * Do these biomarkers change during clinical changes in individuals with RTT? * Are biomarkers stable over time in clinically stable individuals? * Do these biomarkers correlate with severity of RTT? Participants will be asked to undergo an electroencephalogram (EEG) with measurements of Evoked Potentials (EP) to measure electrical activity in the brain. Researchers will compare findings in individuals with RTT to those in typically developing individuals to see if there are differences between the two groups.
Recruiting1 award N/A2 criteria
More about Eric Marsh, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Eric Marsh, MD, PhD has experience with
- Soticlestat
- Ketamine
- Clemizole Hydrochloride
- TSHA-102
- Placebo
Breakdown of trials Eric Marsh, MD, PhD has run
Rett Syndrome
Myoclonic Astatic Epilepsy
Lennox Gastaut Syndrome
Seizures
Dravet Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Marsh, MD, PhD specialize in?
Eric Marsh, MD, PhD focuses on Rett Syndrome and Myoclonic Astatic Epilepsy. In particular, much of their work with Rett Syndrome has involved MECP2 positive patients, or patients who are undergoing treatment.
Is Eric Marsh, MD, PhD currently recruiting for clinical trials?
Yes, Eric Marsh, MD, PhD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Eric Marsh, MD, PhD has studied deeply?
Yes, Eric Marsh, MD, PhD has studied treatments such as Soticlestat, Ketamine, Clemizole Hydrochloride.
What is the best way to schedule an appointment with Eric Marsh, MD, PhD?
Apply for one of the trials that Eric Marsh, MD, PhD is conducting.
What is the office address of Eric Marsh, MD, PhD?
The office of Eric Marsh, MD, PhD is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.